Healthcare provider profile · identity verified

Peter B Ragonesi, MD

Internal Medicine · WINSTON SALEM, NC · NPI 1558349811

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	754	195
Amlodipine Besylate	Amlodipine Besylate	486	133
Lisinopril	Lisinopril	372	100
Losartan Potassium	Losartan Potassium	367	105
Gabapentin	Gabapentin	364	78
Levothyroxine Sodium	Levothyroxine Sodium	317	84
Metoprolol Succinate	Metoprolol Succinate	300	88
Omeprazole	Omeprazole	280	75
Hydrochlorothiazide	Hydrochlorothiazide	266	67
Alprazolam	Alprazolam	220	41
Metformin Hcl	Metformin Hcl	212	55
Zolpidem Tartrate	Zolpidem Tartrate	197	30
Simvastatin	Simvastatin	189	56
Rosuvastatin Calcium	Rosuvastatin Calcium	175	53
Sertraline Hcl	Sertraline Hcl	172	41
Metformin Hcl Er	Metformin Hcl	170	45
Trazodone Hcl	Trazodone Hcl	167	39
Pantoprazole Sodium	Pantoprazole Sodium	156	44
Furosemide	Furosemide	153	44
Albuterol Sulfate Hfa	Albuterol Sulfate	151	45
Meloxicam	Meloxicam	150	34
Allopurinol	Allopurinol	135	34
Lorazepam	Lorazepam	120	26
Fluticasone Propionate	Fluticasone Propionate	117	53
Famotidine	Famotidine	106	29
Jardiance	Empagliflozin	106	20
Glipizide Er	Glipizide	104	26
Ezetimibe	Ezetimibe	100	23
Metoprolol Tartrate	Metoprolol Tartrate	100	30
Pravastatin Sodium	Pravastatin Sodium	98	27
Carvedilol	Carvedilol	94	17
Escitalopram Oxalate	Escitalopram Oxalate	93	19
Tamsulosin Hcl	Tamsulosin Hcl	93	24
Terazosin Hcl	Terazosin Hcl	91	21
Tizanidine Hcl	Tizanidine Hcl	89	25
Eliquis	Apixaban	83	20
Triamcinolone Acetonide	Triamcinolone Acetonide	78	33
Glipizide	Glipizide	69	16
Citalopram Hbr	Citalopram Hydrobromide	68	17
Potassium Chloride	Potassium Chloride	67	22
Glimepiride	Glimepiride	66	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	64	18
Hydroxyzine Hcl	Hydroxyzine Hcl	62	18
Paroxetine Hcl	Paroxetine Hcl	61	20
Baclofen	Baclofen	60	17
Clonazepam	Clonazepam	60	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	59	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	59	17
Bupropion Hcl Sr	Bupropion Hcl	58	13
Montelukast Sodium	Montelukast Sodium	58	18
Warfarin Sodium	Warfarin Sodium	58	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	53	15
Celecoxib	Celecoxib	52	14
Duloxetine Hcl	Duloxetine Hcl	52	14
Doxycycline Hyclate	Doxycycline Hyclate	49	27
Atenolol	Atenolol	48	13
Prednisone	Prednisone	48	33
Tramadol Hcl	Tramadol Hcl	47	22
Donepezil Hcl	Donepezil Hcl	46	13
Clopidogrel	Clopidogrel Bisulfate	44	14
Januvia	Sitagliptin Phosphate	44	suppressed
Ondansetron Hcl	Ondansetron Hcl	44	14
Cefdinir	Cefdinir	43	36
Mirtazapine	Mirtazapine	42	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	42	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	42	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	41	12
Buspirone Hcl	Buspirone Hcl	40	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	suppressed
Synthroid	Levothyroxine Sodium	39	11
Xarelto	Rivaroxaban	39	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	38	11
Sumatriptan Succinate	Sumatriptan Succinate	38	suppressed
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	35	11
Hydralazine Hcl	Hydralazine Hcl	34	suppressed
Bupropion Xl	Bupropion Hcl	33	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	suppressed
Diclofenac Sodium	Diclofenac Sodium	33	suppressed
Azelastine Hcl	Azelastine Hcl	31	12
Doxazosin Mesylate	Doxazosin Mesylate	31	suppressed
Finasteride	Finasteride	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Ozempic	Semaglutide	28	suppressed
Meclizine Hcl	Meclizine Hcl	27	11
Fenofibrate	Fenofibrate Nanocrystallized	26	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	26	26
Temazepam	Temazepam	26	suppressed
Indapamide	Indapamide	24	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	24	suppressed
Propranolol Hcl Er	Propranolol Hcl	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Fluconazole	Fluconazole	22	12
Lansoprazole	Lansoprazole	22	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	22	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Valsartan	Valsartan	22	suppressed
Ventolin Hfa	Albuterol Sulfate	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Colchicine	Colchicine	21	11
Fenofibrate	Fenofibrate	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	20	suppressed
Telmisartan	Telmisartan	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Testosterone Cypionate	Testosterone Cypionate	19	suppressed
Colestipol Hcl	Colestipol Hcl	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	11
Nitrofurantoin	Nitrofurantoin Macrocrystal	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	17
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Cephalexin	Cephalexin	16	13
Ketoconazole	Ketoconazole	16	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	14	suppressed
Erythromycin	Erythromycin Base	14	suppressed
Topiramate	Topiramate	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	12
Estradiol	Estradiol	13	suppressed
Felodipine Er	Felodipine	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Primidone	Primidone	13	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	13	suppressed
Alendronate Sodium	Alendronate Sodium	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Colesevelam Hcl	Colesevelam Hcl	12	suppressed
Epinephrine	Epinephrine	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Naproxen	Naproxen	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error